Inbakicept is an IL-15 receptor activator, consisting of IL-15 mutant and IL-15Ralpha-Fc fusion. Inbakicept magnifies anti-CD20 mAb-mediated NK-cell responses and antibody-dependent cellular cytotoxicity (ADCC). Inbakicept also increases degranulation, IFNgamma production in cells.
Purity:
>98.5%
CAS Number:
[2135939-52-3]
Target:
IL Receptor/Related
* VAT and and shipping costs not included. Errors and price changes excepted